Kevin Daniels - 01 Dec 2023 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Dec 2023, 16:51:14 UTC
Prior SEC filing
21 Feb 2023
Next SEC filing
03 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Tattoli, Attorney-in-Fact

Key filing fact

Kevin Daniels filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 04 Dec 2023.

Key facts

  • This page summarizes Kevin Daniels's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Dec 2023, 16:51.

Change

  • Previous filing in this sequence was filed on 21 Feb 2023.
  • Current net transaction value: -$976.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLB transaction

Common Stock

Tax liability

Transaction value
$976
Shares
-54
Change %
-0.61%
Price
$18.07
Shares after
8,749
Date
01 Dec 2023
Ownership
Direct
CLB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+140
Change %
+1.6%
Price
$0.000000
Shares after
8,803
Date
01 Dec 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLB transaction Derivative

Restricted Shares

Options Exercise

Transaction value
$0
Shares
-140
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Dec 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
140
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .